Table 1.
Multivariable logistic regression analyses predicting PrEP discussion with peers
| ALL GENDERSa
N = 166/1405 |
FEMALEb
n = 43/379 |
MALEc
n = 119/1009 |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N (%) | AOR | (95% CI) | p-value | n (%) | AOR | (95% CI) | p-value | n (%) | AOR | (95% CI) | p-value | |
| Age (years) | ||||||||||||
| < 30 | 12 (16.7) | 1.5 | 0.7–2.9 | 8 (17.8) | 1.3 | 0.5–3.0 | 0.568 | |||||
| 30–40 | 45 (16.7) | 1.6 | 1.0–2.3 | 0.034 | 32 (18.1) | 1.7 | 1.1–2.8 | 0.026 | ||||
| > 40 | 109 (10.2) | 1 | 79 (10.0) | 1 | ||||||||
| Socio-economic category | ||||||||||||
| Without occupation | 30 (11.3) | 1 | 7 (6.2) | 1 | 21 (14.8) | 1 | ||||||
| Farmers/Intermediary workers | 47 (9.4) | 0.9 | 0.5–1.4 | 0.659 | 12 (10.7) | 1.7 | 0.6–4.7 | 0.316 | 33 (8.5) | 0.6 | 0.3–1.1 | 0.087 |
| Employee/Intellectual workers | 72 (16.9) | 1.7 | 1.0–2.7 | 0.036 | 19 (17.8) | 3.8 | 1.4–10.2 | 0.007 | 53 (16.7) | 1.2 | 0.6–2.1 | 0.608 |
| Retired | 17 (8.1) | 0.8 | 0.4–1.6 | 0.549 | 5 (10.6) | 1.7 | 0.5–6 | 0.395 | 12 (7.3) | 0.6 | 0.3–1.3 | 0.189 |
| Member of HIV associations | ||||||||||||
| Yes | 51 (21.3) | 2.4 | 1.6–3.5 | <0.001 | 11 (19.0) | 2.4 | 1.1–5.4 | 0.028 | 37 (21.1) | 2.4 | 1.6–3.8 | <0.001 |
| Undetectable HIV RNA | ||||||||||||
| No | 14 (20.3) | 2.5 | 1.1–5.3 | 0.023 | ||||||||
| Route of HIV transmission | ||||||||||||
| Heterosexual intercourse | 41 (8.7) | 1 | 19 (7.7) | 1 | ||||||||
| Homo/Bisexual intercourse | 74 (15.8) | 1.7 | 1.1–2.6 | 0.015 | 66 (15.4) | 1.8 | 1.0–3.1 | 0.041 | ||||
| Intravenous Drug Use | 32 (14.0) | 2.0 | 1.2–3.4 | 0.008 | 22 (12.9) | 2.0 | 1.0–4.0 | 0.038 | ||||
| Other/unknown | 19 (7.9) | 1.0 | 0.5–1.7 | 0.967 | 12 (7.4) | 1.0 | 0.5–2.2 | 0.915 | ||||
| CD4 count/mm3 | ||||||||||||
| < 200 | 21 (17.9) | 2.1 | 1.2–3.7 | 0.009 | 7 (19.4) | 2.9 | 1.0–8.5 | 0.050 | ||||
| 200–499 | 45 (12.0) | 1.2 | 0.8–1.8 | 0.325 | 12 (12.5) | 1.5 | 0.7–3.6 | 0.308 | ||||
| 500+ | 75 (11.2) | 1 | 16 (8.2) | 1 | ||||||||
| NR/ND | 25 (10.4) | 1.2 | 0.7–2.0 | 0.501 | 8 (15.4) | 2.1 | 0.8–5.8 | 0.144 | ||||
| Partners’ number (last 3 months) | ||||||||||||
| No partner | 39 (8.8) | 1 | 14 (9.2) | 1 | 25 (8.6) | 1 | ||||||
| Single partner | 86 (11.7) | 1.2 | 0.8–1.8 | 0.490 | 24 (11.2) | 1.3 | 0.6–2.7 | 0.545 | 61 (11.8) | 1.3 | 0.8–2.1 | 0.347 |
| Multiple partners | 41 (18.1) | 1.7 | 1.0–2.9 | 0.042 | 5 (45.5) | 8.9 | 2.1–37.7 | 0.003 | 33 (16.4) | 1.6 | 0.9–3.0 | 0.096 |
AOR adjusted odds ratio, CI confidence interval, ART antiretroviral therapy, STI sexually transmitted infection
aIncluding Transgender persons (n = 4/17). Significant variables at univariate analysis (p < 0.100): Gender (forced variable); Age; Socio-economic category; Member of HIV associations; Route of HIV transmission; CD4 count/mm3; STI (last 12 months); Partners’ number (last 3 months)
bSignificant variables at univariate analysis (p < 0.100): Age (forced variable); Socio-economic category; Member of HIV associations; Undetectable HIV RNA; CD4 count/mm3; Partners’ number (last 3 months)
cSignificant variables at univariate analysis (p < 0.100): Age; Place of residence; Socio-economic category; Member of HIV associations; Route of HIV transmission; Partners’ number (last 3 months)